Webinar Recorded on Feb. 13, 2024                             Pricing: Free for Members and Non-Members

Please note that this session is not accredited for continuing pharmacy education credit.

Program Description

This webinar will feature a candid conversation with panelists from AMCP's Market Insights Roundtable on Optimizing the Management of Inherited Blood Disorders, Part 2 - a follow-up program to the 2022 Roundtable. Speakers will provide an overview of the current and evolving coverage and treatment landscapes for Hemophilia, Sickle Cell, and Beta Thalassemia.

Speakers will share insights from the roundtable discussion which includes the effects of recently approved therapies on clinicians, payers, and patients; emerging trends within the stop loss market; potential issues and obstacles related to monitoring and reporting outcomes; and identifying concerns associated with both existing and emerging contracting and reimbursement models. Speakers will also share the findings of a national bleeding disorder center of excellence (COE) survey and managed care insights around coverage and access to treatments for inherited blood disorders.